SPONSOR

Yonsei University

Total Trials

Recruiting

Phases

Phase 2, Phase 1, Phase 2, Phase 4

Conditions studied: Gait Disorders, Neurologic Cerebral Palsy No Restriction on Disease Cancer Hepatocellular Carcinoma Liver Neoplasms Carcinoma Hepatocellular Gastric Cancer Gastroesophageal Junction (GEJ) Cancer

Yonsei University is a clinical research sponsor with 23 registered studies on ClinicalTrials.gov, of which 23 are actively recruiting participants. Research covers conditions including Gait Disorders, Neurologic, Cerebral Palsy, No Restriction on Disease, Cancer.

The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Yonsei University

How many clinical trials has Yonsei University sponsored?

ClinicalMetric currently tracks 23 clinical trials sponsored by Yonsei University, of which 23 are actively recruiting participants. These trials cover conditions including Gait Disorders, Neurologic, Cerebral Palsy, No Restriction on Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Yonsei University research focus on?

Yonsei University clinical trials span Gait Disorders, Neurologic, Cerebral Palsy, No Restriction on Disease, Cancer, Hepatocellular Carcinoma, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Yonsei University clinical trial?

To participate in a Yonsei University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yonsei University trials with current recruitment status updated daily.

Yonsei University

Frequently Asked Questions — Yonsei University

Clinical Trials by Yonsei University

Home-based Gait Rehabilitation Service Using the Insole-type Gait Analysis Device for Children With Cerebral Palsy

Routine Electronic Patient-reported Outcome Measures During and After Radiotherapy: A Randomized Controlled Study

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation

Impact of Dynamic CoROnary RoADmap System for Guidance of Instantaneous Wave-Free Ratio or Fractional Flow Reserve

Effectiveness and Safety of Electrically Powered Orthopedic Exercise Device for Gait Disorders

KOMATE Registry: Korean Multicenter Angioplasty Team

Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study

Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)

Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in de Novo HFrEF

First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury

Ultrasonic Versus Conventional Clipping Hemostasis in Laparoscopic Colorectal Surgery

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

The Characteristics and Treatment Mechanism of Vascular Grafts in Elderly Patients With CAOD Through Single-cell Transcriptome Analysis

Exercise Program in Patients With Nontuberculous Mycobacterial Pulmonary Disease

Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics

Aspirin vs Clopidogrel After TAVR

Economic and Clinical Benefit of Remote Monitoring Among Defibrillator Patients by Indication Subgroups (BENEFIT-RM)

The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study

LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea

Impact of Virtual Reality (VR) and Music Intervention